Ciba-Geigy Ltd. said it extended its research collaboration with Affymax NV of Amsterdam for an additional year.
Ciba-Geigy is currently funding drug discovery research at Affymax under an agreement initiated in July 1991.
Affymax is involved in identifying drug candidates that interact with certain undisclosed molecular targets, while Ciba-Geigy will be responsible for clinical development and marketing of compounds discovered under the agreement.
